Clinical Trials Logo

Plaque Psoriasis Patients clinical trials

View clinical trials related to Plaque Psoriasis Patients.

Filter by:
  • None
  • Page 1

NCT ID: NCT06299982 Not yet recruiting - Clinical trials for Plaque Psoriasis Patients

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Start date: May 15, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examin the efficacy and safety of the study drug recombinant anti-IL-17A humanized monoclonal antibody in Chinese participants with moderate-to-severe plaque psoriasis.

NCT ID: NCT01557283 Completed - Clinical trials for Plaque Psoriasis Patients

An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria

BEFLEX
Start date: September 2011
Phase: N/A
Study type: Observational

With the new reimbursement criteria, we want: To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year. To describe the number of patients who receive continuous treatment To describe the number of patients who receive intermittent treatment To describe the number of weeks off treatment